|
|
|
| Crohn's Disease Could Be Treated With Banana Plantain Fibers | Fri, 27 Aug 2010 |
| Crohn's is a condition that affects one in 800 people in the UK and causes chronic intestinal inflammation, leading to pain, bleeding and diarrhoea. Researchers are working with biotechnology company, Provexis, to test a new plantain based food product that could treat patients with the disease... | |
|
|
| Encouraging Data On Preventing Crohn's Disease Recurrence | Sat, 07 Aug 2010 |
| Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. "Post-surgical recurrence of Crohn's disease occurs very frequently... | |
|
|
|
|
| A Step Towards A New Therapy For Chronic Bowel Disease | Wed, 07 Jul 2010 |
| Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University (UGent) have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs... | |
|
|
|
| Measurement Of C-Reactive Protein In Pediatric Inflammatory Bowel Disease Patients | Sat, 26 Jun 2010 |
| C-reactive protein (CRP) is used to assess disease activity in diverse inflammatory disorders including inflammatory bowel disease (IBD). However, in IBD, a significant number of patients present with low CRP levels despite clinically active disease. In paediatric patients with IBD the performance of CRP is an understudied area... | |
| A Future Strategy For The Treatment Of Patients With Ulcerative Colitis | Sat, 26 Jun 2010 |
| Ulcerative colitis (UC) is characterized by frequent diarrheal attacks and anal bleeding. Histologic characteristics of UC are the invasion of the crypt epithelium and lamina propria by peripheral blood mononuclear cells (PBMCs), disruption of the epithelial lining, and consequently mucosal ulceration and crypt abscess formation in the bowel wall... | |
| Virus Works With Gene To Cause Crohn's-Like Illness | Fri, 25 Jun 2010 |
| Scientists have shown that a specific virus can interact with a mutation in the host's genes to trigger disease. The observation may help explain why many people with disease risk genes do not actually develop disease. Researchers at Washington University School of Medicine in St... | |
|
|
| Symptoms Of Digestive Disorders Alleviated By Probiotic Found In Breast Milk | Fri, 04 Jun 2010 |
| New research published in the FASEB Journal suggests that Lactobacillus reuteri immediately affects nerves in the gut, explaining how probiotics work Here's another reason to breast feed your baby: Canadian researchers have discovered how a probiotic found in breastmilk reduces or eliminates painful cramping in the gut... | |
| Inflammatory Bowel Disease May Be Eased By Use Of Local Anesthetics | Thu, 03 Jun 2010 |
| Inflammatory bowel disease (IBD) is a disease of the gastrointestinal tract, mainly the intestines, that may occur in those people who have genetic potential combined with environmental factors. There has been no definitive medical treatment and drugs usually just relieve the symptoms. Local anesthetics are used to locally desensitize the tissues to allow surgical interventions... | |
| Prescription Charges Unchanged For People With Longterm Medical Conditions Crohn's And Colitis | Tue, 01 Jun 2010 |
| The National Association for Colitis and Crohn's disease (NACC) has welcomed the publication of Professor Ian Gilmore's review on prescription charge exemption for people with long term conditions, and calls on the new coalition government to act on his considered and clearly presented proposals to abolish prescription charges for people in England who are living with liv... | |
|
| When Helper Cells Aren't Helpful | Mon, 24 May 2010 |
| Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells... | |
| NICE Recommends Two More Treatments For Crohn's Disease | Thu, 20 May 2010 |
| NICE has announced that it has recommended two treatments (infliximab and adalimumab) for people with severe Crohn's disease. The guidance approves use of the drugs for people who have not responded to, who are intolerant of, or are unable to take more commonly used therapies to treat the condition... | |
